共 50 条
- [41] INITIATING HIGH-DOSE ORAL TESTOSTERONE UNDECANOATE THERAPY IN HYPOGONADAL MEN: SAFETY, EFFICACY, AND PATIENT SATISFACTION JOURNAL OF SEXUAL MEDICINE, 2024, 21
- [46] PROSTATE CANCER IS LESS FREQUENT AND SEVERE IN HYPOGONADAL MEN TREATED ADEQUATELY WITH TESTOSTERONE UNDECANOATE INJECTIONS (TU) FOR UP TO 8 YEARS COMPARED TO UNTREATED HYPOGONADAL CONTROLS JOURNAL OF UROLOGY, 2016, 195 (04): : E236 - E236
- [47] ERECTILE FUNCTION IN 164 MATCHED HYPOGONADAL MEN: RESULTS OF LONG TERM TREATMENT WITH TESTOSTERONE UNDECANOATE INJECTIONS (TU) IN COMPARISON WITH CONTROL GROUP JOURNAL OF SEXUAL MEDICINE, 2017, 14 (01): : S3 - S3
- [48] LONG-TERM TREATMENT WITH TESTOSTERONE UNDECANOATE (TU) IN HYPOGONADAL MEN WITH CARDIOVASCULAR DISEASES (CVD): OBSERVATIONAL DATA FROM A REGISTRY STUDY JOURNAL OF UROLOGY, 2015, 193 (04): : E771 - E771
- [49] ERECTILE FUNCTION IN 656 HYPOGONADAL MEN IMPROVES OVER 8 YEARS WITH TESTOSTERONE UNDECANOATE INJECTIONS (TU) IN COMPARISON TO AN UNTREATED CONTROL GROUP JOURNAL OF UROLOGY, 2017, 197 (04): : E1222 - E1222